The study was conducted by the Inner City Asthma Consortium (ICAC), which is funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The Sept. 20 issue of The Lancet reports the ICAC findings.
Approximately 550 adolescents in 10 cities across the United States participated in the study. It was designed to examine whether in addition to treating asthma based on national guidelines developed at NIH, measurements of exhaled nitric oxide would allow even better control of the disease. This was the largest study to date testing exhaled nitric oxide as a biomarker for asthma management.
Asthma is a chronic disorder of the airways that affects approximately 9 percent of children under age 17 in the United States. The causes of asthma are still unknown, but allergens, air pollution and infections can provoke its symptoms, which include wheezing, chest tightness, shortness of breath and coughing. Asthma symptoms occur when the tissues of the lungs become inflamed and the muscles in the airways contract, making breathing difficult. One measurable marker of asthma-related inflammation is high levels of nitric oxide (NO) in the breath; it is known that the higher the exhaled NO, the greater the inflammation of the lungs. Equipment is now available to easily measure exhaled NO. Widely used asthma treatments, such as inhaled corticosteroids, reduce both lung inflammation and exhaled NO. Exhaled NO would potentially be a good biomarker—a measurable feature of a disease that indicates its severity—of asthma inflammation.
"A biomarker of airway inflammation could be a useful clinical tool for gauging medical needs and clinical responses in asthma patients," says Anthony S. Fauci, M.D., director of NIAID. "Although this study reinforces the importance of the NIH asthma guidelines for disease control, it did not find that measuring exhaled nitric oxide provided any additional clinical benefit."
The new research was led by Stanley Szefler, M.D., of National Jewish Health in Denver, in conjunction with William Busse, M.D., of the University of Wisconsin in Madison. Participants were randomly assigned to one of two equal-sized groups: one group received treatment based on the NIH National Asthma Education and Prevention Program (NAEPP) guidelines alone, and the other received treatment based on the guidelines plus measurement of exhaled NO. The year-long study compared participants' symptoms and asthma exacerbations.
According to Dr. Szefler, "The hypothesis was that adding exhaled NO monitoring to the NIH asthma guidelines-based approach would improve asthma control over the guidelines-based approach alone." Researchers had hoped that exhaled NO would indicate if there was a need for increased treatment dosage in the participants who had few asthma symptoms but who had ongoing high levels of lung inflammation. Although measuring exhaled NO is not routine practice in asthma management, this study was aimed at determining whether it should be included in treating patients in the future.
In the end, the study found that the group whose treatment was guided by exhaled NO did not end up with fewer or less severe asthma symptoms or fewer asthma exacerbations compared with the group that received treatment based on the NAEPP guidelines alone.
Most patients in each group had marked improvement in their asthma initially and throughout the study, highlighting the importance of optimizing asthma treatment according to the NIH guidelines. According to Dr. Busse, the upside of the study is that "good adherence to the current guidelines [for treating asthma patients] can mean good disease management without the need for a biomarker." This is particularly important because the study was conducted in an inner-city population, which historically has suffered from more difficult-to-treat asthma and disproportionately higher mortality from asthma due to the lack of optimal management, according to Peter Gergen, M.D., the NIAID medical officer overseeing the study.
Julie Wu | EurekAlert!
Multi-year study finds 'hotspots' of ammonia over world's major agricultural areas
17.03.2017 | University of Maryland
Diabetes Drug May Improve Bone Fat-induced Defects of Fracture Healing
17.03.2017 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
24.03.2017 | Materials Sciences
24.03.2017 | Physics and Astronomy
24.03.2017 | Physics and Astronomy